Benzinga··Equity-Insider.ComBiotech Breakthrough: Avaí Bio Moves Anti-Aging Protein Therapy Into Production
Avaí Bio begins manufacturing genetically modified cells overexpressing α-Klotho protein, an anti-aging compound that naturally declines 50% after age 40, advancing its Cell-in-a-Box platform.
MESOMNKDLGVNAVAILCTXregenerative medicinecell therapy